1. A randomized, double‐blind, phase 2 trial of platinum therapy plus etoposide with or without concurrent vandetanib (ZD6474) in patients with previously untreated extensive‐stage small cell lung cancer: Hoosier Cancer Research Network LUN06‐113. Issue 2 (1st September 2016) Authors: Sanborn, Rachel E.; Patel, Jyoti D.; Masters, Gregory A.; Jayaram, Nagesh; Stephens, Anthony; Guarino, Michael; Misleh, Jamal; Wu, Jingwei; Hanna, Nasser Journal: Cancer Issue: Volume 123:Issue 2(2017) Page Start: 303 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Atezolizumab in patients with advanced non-small cell lung cancer and history of asymptomatic, treated brain metastases: Exploratory analyses of the phase III OAK study. (February 2019) Authors: Gadgeel, Shirish M.; Lukas, Rimas V.; Goldschmidt, Jerome; Conkling, Paul; Park, Keunchil; Cortinovis, Diego; de Marinis, Filippo; Rittmeyer, Achim; Patel, Jyoti D.; von Pawel, Joachim; O'Hear, Carol; Lai, Catherine; Hu, Sylvia; Ballinger, Marcus; Sandler, Alan; Gandhi, Mayank; Fehrenbacher, Lou Journal: Lung cancer Issue: Volume 128(2019) Page Start: 105 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Effects of Rovalpituzumab Tesirine on Ventricular Repolarization in Patients With Small‐Cell Lung Cancer. Issue 2 (19th December 2020) Authors: Goldman, Jonathan W.; Barve, Minal; Patel, Jyoti D.; Wozniak, Antoinette; Dowlati, Afshin; Starodub, Alexander; Owonikoko, Taofeek K.; Edenfield, William; Laurie, Scott A.; Da Costa, Daniel; Lally, Satwant; Koch, Martina; Kosloski, Matthew P.; Hoffman, David; Dy, Grace K. Journal: Clinical and translational science Issue: Volume 14:Issue 2(2021) Page Start: 664 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Efficacy and Safety of Larotrectinib in Patients With Tropomyosin Receptor Kinase Fusion–Positive Lung Cancers. (27th January 2022) Authors: Drilon, Alexander; Tan, Daniel S. W.; Lassen, Ulrik N.; Leyvraz, Serge; Liu, Yongmei; Patel, Jyoti D.; Rosen, Lee; Solomon, Benjamin; Norenberg, Ricarda; Dima, Laura; Brega, Nicoletta; Shen, Lin; Moreno, Victor; Kummar, Shivaani; Lin, Jessica J. Journal: JCO precision oncology Issue: Volume 6(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Indirect comparison of mobocertinib and real-world therapies for pre-treated non-small cell lung cancer with EGFR exon 20 insertion mutations. (May 2023) Authors: Christopoulos, Petros; Prawitz, Thibaud; Hong, Jin-Liern; Lin, Huamao M.; Hernandez, Luis; Jin, Shu; Tan, Min; Proskorovsky, Irina; Lin, Jianchang; Zhang, Pingkuan; Patel, Jyoti D.; Ou, Sai-Hong I.; Thomas, Michael; Stenzinger, Albrecht Journal: Lung cancer Issue: Volume 179(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Is immune checkpoint inhibition part of standard therapy for stage III non‐small cell lung cancer?. Issue 14 (15th June 2018) Authors: Patel, Jyoti D.; Chmura, Steven J. Journal: Cancer Issue: Volume 124:Issue 14(2018) Page Start: 2878 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Isolating the Role of Bevacizumab in Elderly Patients With Previously Untreated Nonsquamous Non–Small Cell Lung Cancer: Secondary Analyses of the ECOG 4599 and PointBreak Trials. (October 2016) Authors: Langer, Corey J.; Socinski, Mark A.; Patel, Jyoti D.; Sandler, Alan B.; Schiller, Joan H.; Leon, Larry; Hazard, Sebastien J.; Ramalingam, Suresh S. Journal: American journal of clinical oncology Issue: Volume 39:Number 5(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Maintenance treatment after induction therapy in non-small cell lung cancer: latest evidence and clinical implications. (January 2014) Authors: Gentzler, Ryan D.; Patel, Jyoti D. Journal: Therapeutic advances in medical oncology Issue: Volume 6:Number 1(2014:Jan.) Page Start: 4 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Management of Stage III Non–Small-Cell Lung Cancer: ASCO Guideline. Issue 12 (20th April 2022) Authors: Daly, Megan E.; Singh, Navneet; Ismaila, Nofisat; Antonoff, Mara B.; Arenberg, Douglas A.; Bradley, Jeffrey; David, Elizabeth; Detterbeck, Frank; Früh, Martin; Gubens, Matthew A.; Moore, Amy C.; Padda, Sukhmani K.; Patel, Jyoti D.; Phillips, Tanyanika; Qin, Angel; Robinson, Clifford; Simone, Char... Journal: Journal of clinical oncology Issue: Volume 40:Issue 12(2022) Page Start: 1356 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Quality of Life Analyses from the Randomized, Open-Label, Phase III PointBreak Study of Pemetrexed-Carboplatin-Bevacizumab followed by Maintenance Pemetrexed-Bevacizumab Versus Paclitaxel-Carboplatin-Bevacizumab followed by Maintenance Bevacizumab in Patients with Stage IIIB or IV Nonsquamous Non–Small-Cell Lung Cancer. Issue 2 (February 2015) Authors: Spigel, David R.; Patel, Jyoti D.; Reynolds, Craig H.; Garon, Edward B.; Hermann, Robert C.; Govindan, Ramaswamy; Olsen, Mark R.; Winfree, Katherine B.; Chen, Jian; Liu, Jingyi; Guba, Susan C.; Socinski, Mark A.; Bonomi, Philip Journal: Journal of thoracic oncology Issue: Volume 10:Issue 2(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗